Lloyds Banking Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2014
Q4 | – | Sell |
-3,271
| Closed | -$542K | – | 434 |
|
|
2014
Q3 | $542K | Sell |
3,271
-382
| -10% | -$63.3K | 0.15% | 169 |
|
|
2014
Q2 | $570K | Sell |
3,653
-44,834
| -92% | -$7M | 0.14% | 174 |
|
|
2014
Q1 | $7.38M | Buy |
48,487
+5,591
| +13% | +$851K | 0.07% | 245 |
|
|
2013
Q4 | $5.71M | Buy |
42,896
+3,139
| +8% | +$418K | 0.05% | 280 |
|
|
2013
Q3 | $4.62M | Buy |
39,757
+2,746
| +7% | +$319K | 0.05% | 281 |
|
|
2013
Q2 | $3.41M | Buy |
+37,011
| New | +$3.41M | 0.04% | 315 |
|